Bayesian Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,824
Closed -$438K 787
2025
Q2
$438K Buy
+1,824
New +$425K 0.07% 313
2024
Q1
Sell
-4,000
Closed -$879K 1103
2023
Q4
$879K Buy
+4,000
New +$846K 0.09% 260
2023
Q3
Sell
-4,800
Closed -$1.08M 991
2023
Q2
$1.08M Buy
+4,800
New +$960K 0.12% 239
2023
Q1
Sell
-3,029
Closed -$559K 1070
2022
Q4
$559K Buy
+3,029
New +$533K 0.08% 320
2021
Q3
Sell
-1,100
Closed -$227K 530
2021
Q2
$227K Buy
+1,100
New +$221K 0.06% 345
2020
Q2
Sell
-2,680
Closed -$375K 770
2020
Q1
$375K Sell
2,680
-4,900
-65% -$733K 0.08% 377
2019
Q4
$1.16M Buy
7,580
+3,600
+90% +$528K 0.2% 151
2019
Q3
$575K Buy
+3,980
New +$595K 0.11% 244
2017
Q4
Sell
-13,119
Closed -$1.16M 715
2017
Q3
$1.16M Buy
+13,119
New +$1.11M 0.28% 115

Other funds holding STE

Bayesian Capital Management's STE Position: Q3 2025 in Review

Bayesian Capital Management sold out of Steris (STE) in Q3 2025, closing a stake of 1,824 shares — an estimated $438K sold.

Bayesian Capital Management first reported a position in STE in Q3 2017 and held it in 9 quarters. The position peaked at $1.16M in Q3 2017. 844 funds tracked by Wall St. Rank hold STE as of Q3 2025.

  • Bayesian Capital Management reported no remaining Steris position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 1,824 Steris shares in Q3 2025, an estimated $438K.
  • Bayesian Capital Management first reported a position in Steris in Q3 2017 and held it in 9 quarters.
  • Bayesian Capital Management's Steris position peaked at $1.16M in Q3 2017.
  • 844 funds tracked by Wall St. Rank held Steris as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.